Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-04 Sale |
2024-03-06 4:48 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
16,727 | $4.2997 | $71,921 | 129,789 (Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:23 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,724 | $5.84 | $21,748 | 113,816 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:26 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
11,833 | $6.2636 | $74,117 | 117,540 (Direct) |
View |
| 2022-08-22 Sale |
2022-08-23 5:01 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,605 | $10.27 | $37,007 | 96,673 (Direct) |
View |
| 2022-03-02 Sale |
2022-03-02 9:28 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
6,974 | $11.19 | $78,060 | 177,778 (Direct) |
View |
| 2021-08-20 Sale |
2021-08-23 4:36 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,650 | $15.39 | $56,190 | 74,552 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-03 6:42 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,888 | $18.45 | $71,729 | 78,202 (Direct) |
View |
| 2020-08-20 Sale |
2020-08-21 6:08 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,710 | $11.08 | $41,109 | 56,290 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Tax Withholding |
2025-03-04 4:46 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
15,520 | $4.76 | 239,269 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 8:21 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
125,000 | $0 | 254,789 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:52 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
32,700 | $0 | 146,516 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:11 pm |
N/A 2033-02-15 |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
110,200 | $0 | 206,873 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:28 pm |
N/A 2032-02-27 |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
110,200 | $0 | 177,778 (Direct) |
View |
| 2021-02-24 Option Award |
2021-02-26 5:19 pm |
N/A 2031-02-23 |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
87,000 | $0 | 143,290 (Direct) |
View |